top of page

Paul Ornstein, Ph.D. joins as VP of Preclinical Development

Function Therapeutics is pleased to welcome Dr. Paul Ornstein as its VP of Preclinical Development. Paul trained with a series of legendary organic chemists (Mike Jung, Barry Trost, and Dave Evans) prior to his distinguished career at Eli Lilly as a Research Fellow in medicinal chemistry, specializing in CNS drug discovery. More recently, Paul served as Associate Professor of Medicinal Chemistry at Roosevelt University and the Medical College of Wisconsin, and he is the principal of Apollo Drug Discovery Consulting. Paul will be working with the team at Function Therapeutics to advance the best possible compounds towards clinical stages.


Les commentaires ont été désactivés.


bottom of page